Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly

被引:70
|
作者
Warzok, RW [1 ]
Kessler, C
Apel, G
Schwarz, A
Egensperger, R
Schreiber, D
Herbst, EW
Wolf, E
Walther, R
Walker, LC
机构
[1] Ernst Moritz Arndt Univ Greifswald, Inst Pathol, Dept Neuropathol, D-17489 Greifswald, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Inst Pathol, Dept Neurol, D-17489 Greifswald, Germany
[3] Ernst Moritz Arndt Univ Greifswald, Inst Pathol, Dept Biochem, D-17489 Greifswald, Germany
[4] Univ Munich, Dept Neuropathol, Munich, Germany
[5] Erfurt Clin, Dept Pathol, Erfurt, Germany
[6] Neubrandenburg Clin, Dept Pathol, Neubrandenburg, Germany
[7] Stralsund Clin, Dept Pathol, Stralsund, Germany
[8] Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA
来源
关键词
aging; Alzheimer disease; amyloid; amyloid angiopathy; senile plaques; neurofibrillary tangles; apolipoprotein E;
D O I
10.1097/00002093-199803000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To evaluate the influence of the apolipoprotein E (ApoE) epsilon 4 allele on the age at which Alzheimer-like lesions appear in the brain, we analyzed the degree of cerebral beta-amyloidosis and neurofibrillary tangle formation in the hippocampal formation and adjacent cortical areas 28, 27, and 36 of persons who had died between the ages of 50 and 93 years and who had shown no signs of clinical dementia. The occurrence of the three common polymorphisms of the ApoE gene in this sample of 147 routine autopsy cases from eastern Germany was comparable to previously reported values in European and North American populations: ApoE epsilon 2/2, 0.7%; ApoE epsilon 2/3, 14.3%; ApoE epsilon 2/4, 4.1%; ApoE epsilon 3/3, 56.5%; ApoE epsilon 3/4, 22.4%; and ApoE epsilon 4/4, 2.0%. Nondemented persons carrying the ApoE epsilon 4 allele were significantly more likely to have senile plaques, diffuse amyloid deposits, cerebrovascular amyloid and neurofibrillary tangles than were those lacking epsilon 4. Comparing the two largest ApoE subgroups, ApoE epsilon 3/3 and ApoE epsilon 3/4, the relative increase in the occurrence of beta-amyloid in the epsilon 3/4 group was evident by the mid-60s, with the relative increase in neurofibrillary tangles in this group emerging slightly earlier. The ApoE epsilon 2 allele appears to delay the appearance of the lesions somewhat. We conclude that ApoE epsilon 4, promotes the early appearance of beta-amyloid and neurofibrillary tangles in the elderly and that the increased frequency of these lesions is related to the higher risk of Alzheimer disease in persons bearing the ApoE epsilon 3 allele.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [31] Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease
    Lorenzo M. Refolo
    Howard M. Fillit
    Journal of Molecular Neuroscience, 2004, 23 : 151 - 155
  • [32] Apolipoprotein E4 is associated with neuronal loss in the substantia nigra in Alzheimer disease
    Camicioli, R
    Kaye, J
    Payami, H
    Ball, M
    Murdoch, G
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (05): : 532 - 532
  • [33] AMINO-TERMINAL CLEAVAGE OF APOLIPOPROTEIN E4 IN ALZHEIMER'S DISEASE
    Coonse, K. G.
    Catlin, L. W.
    Rohn, T. T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 240 - 241
  • [34] Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Aβ peptide
    Poeggeler, B
    Miravalle, L
    Zagorski, MG
    Wisniewski, T
    Chyan, YJ
    Zhang, YB
    Shao, HY
    Bryant-Thomas, T
    Vidal, R
    Frangione, B
    Ghiso, J
    Pappolla, MA
    BIOCHEMISTRY, 2001, 40 (49) : 14995 - 15001
  • [35] Senile dementia and apolipoprotein E4
    McConathy, W
    Lacko, A
    Kalman, J
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (04) : 258 - 258
  • [36] PIB uptake in non-demented elderly apolipoprotein E4 carriers
    Marshall, Gad A.
    Carmasin, Jeremy S.
    Moran, Erin K.
    Eng, Elisha
    Binstock, Anna B.
    Becker, John A.
    Fischman, Alan J.
    Rentz, Dorene M.
    Sperling, Reisa
    Johnson, Keith
    NEUROLOGY, 2008, 70 (11) : A453 - A453
  • [37] Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease
    Hirono, N
    Mori, E
    Yasuda, M
    Imamura, T
    Shimomura, T
    Hashimoto, M
    Tanimukai, S
    Kazui, H
    Yamashita, H
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 11 (01) : 66 - 70
  • [38] Depression and Plasma Amyloid β Peptides in the Elderly With and Without the Apolipoprotein E4 Allele
    Sun, Xiaoyan
    Chiu, Chi Chia
    Liebson, Elizabeth
    Crivello, Natalia A.
    Wang, Lixia
    Claunch, Joshua
    Folstein, Marshal
    Rosenberg, Irwin
    Mwamburi, D. Mkaya
    Peter, Inga
    Qiu, Wei Qiao
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2009, 23 (03): : 238 - 244
  • [39] EVIDENCE FOR EVOLVING DEMENTIA IN APOLIPOPROTEIN (APO-E) E4 POSITIVE NORMAL ELDERLY
    SMITH, GE
    THIBODEAU, S
    TSAI, MS
    TANGALOS, EG
    NEUROLOGY, 1994, 44 (04) : A207 - A207
  • [40] Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology
    Kaufman, Carolyn S.
    Morris, Jill K.
    Vidoni, Eric D.
    Burns, Jeffrey M.
    Billinger, Sandra A.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2021, 35 (03): : 223 - 229